GPC3-HBsAg recombinant protein vaccine (Anti-tumor Biological)

GPC3‑HBsAg重组蛋白疫苗 (广州白云山南方抗肿瘤生物制品)

Report date: 2026/04/23 20:00:25

Base Information

Drug NameGPC3-HBsAg recombinant protein vaccine (Anti-tumor Biological)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionGlypican-3 modulatorsImmunostimulants
TargetsGlypican-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Baiyunshan Southern Anti-tumor Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Baiyunshan Southern Anti-tumor Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A